FDA Investigator Stephen J Koniers
Stephen J Koniers has inspections in 10 countries as of 29 Sep 2023. Stephen J Koniers has collaborated with a combined 2839 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan,
United States of America,
Germany,
India,
China,
Hungary,
Italy,
Austria,
United Kingdom of Great Britain and Northern Ireland,
Israel
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Amy L Singer,
Amy M Cramer,
Anastasia I Offordile,
Anastasia M Shields,
Anita R Michael,
Ankur C Patel,
Anthony A Charity,
Arthur T Ogdahl,
Atul J Agrawal,
Audrey Thereset Uy,
Azza Talaat,
Barbara Jwilimczyk Macri,
Bijoy Panicker,
Bonita S Chester,
Brandon C Heitmeier,
Brandy N Lepage,
CDR Rochelle B Young, RPh, MSA,
Charisse K Green,
Charles M Edwards,
Christopher S Keating,
Colleen M Damon,
Craig D Zagata,
Cynthia A Palmer,
Daniel J Grabicki,
Dawn E Barkans,
Dawn L Wydner,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Dennis Cantellops Paite,
Dorothy J Denes,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Eileen A Liu,
Erika E Englund, PhD,
Erika V Butler,
Felix Maldonado,
Frederick Razzaghi,
Gayle S Lawson,
George Pyramides,
Hala L Selby,
Hala Lj Whetstone,
Helen Verdel,
Heriberto Negron Rivera,
Israel Santiago, OCM,
Ivis Lnegron Torres,
Jaison J Eapen,
James C Illuminati,
James M Mason,
James R Birkenstamm,
Jean Blackston Hill,
Jean Blackstone Hill,
Jennifer J Stone,
Jennifer L Huntington,
Joanne Heim,
Joanne M Hajoway,
John D White,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose M Cayuela,
Jose R Hernandez,
Julianne C Mccullough,
Jullianne C Mccullough,
Junho Pak,
Junho Park,
Kara D Dobbin,
Karen A Briggs,
Karen E D'orazio,
Karyn M Campbell,
Katherine Szestypalow,
Kelli F Dobilas,
Kendra L Brooks,
Kenneth M Gordon,
Kham Phommachanh,
Ko U Min,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
Kristy A Zielny,
Lance M De Souza, MBA,
Larry K Austin,
Lauren N Barber,
Leonard H Lavi,
Linda M Hoover,
Lisa B Orr,
Lisa M Bellows,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Margaret M Annes,
Marie F Morin,
Mary E Storch,
Matthew B Casale,
Matthew R Noonan,
Meena Bansal Gupta, PhD,
Megan A Haggerty,
Melissa J Garcia,
Michael A Charles,
Michael A Taylor,
Michael Gurbarg,
Michael J Kuchta,
Michael L Casner,
Michael L Chasey,
Michael R Klapal,
Michael Serrano,
Michele Gottshall,
Michele L Glendenning,
Michele L Obert,
Michele M Falchek,
Miguel A Martinez,
Mihaly S Ligmond,
Monica M Mcclure,
Monika Borkowska,
Mra Mcculloughj,
Mra Munizn,
Nancy M Espinal,
Nicholas A Violand,
Noreen Muniz,
Parul M Patel,
Patrick C Klotzbuecher,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Rabin N Ghoshal,
Randy L Self,
Raquel Gonzalez Rivera,
Regina T Brown,
Richard E Needham,
Robert B Shibuya, MD,
Robert J Maffei,
Robert M Barbosa,
Roger F Zabinski,
Rose Ljean Mary,
Russell J Glapion,
Russell K Riley,
Saleem A Akhtar,
Sam Pepe,
Santos E Camara,
Satheesh Thomas,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Stephanie Mangigian, MS/OSH, RN,
Steven M Weinman,
Susan F Laska, MS,
Tamil Arasu, PhD,
Tammy L Chavis,
Temar Q Williams,
Thomas E Friel,
Tiffani D Wilson,
Torrance J Slayton,
Vlada Matusovsky,
Yumi J Hiramine,
Yvesna C Blaise,
Zachary A Bogorad
Stephen J Koniers's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2012 | FDA 483 | Aurobindo Pharma Limited - Form 483, 2012-09-21 |
August, 2002 | FDA 483 | Microbac Labs Inc - Form 483, 2002-08-29 |
September, 2012 | FDA 483 | Hikal Limited - Form 483, 2012-09-13 |
January, 2012 | FDA 483 | Frontida BioPharm, LLC - Form 483, 2012-01-27 |
September, 2013 | FDA 483 | Purdy-Pak, Inc. dba Tite-Pak & PPI - Form 483, 2013-09-11 |
December, 2013 | EIR | KVK-TECH, INC. - EIR, 2013-12-09 |
December, 2013 | FDA 483 | KVK-TECH, INC. - Form 483, 2013-12-09 |
July, 2006 | EIR | PEL HEALTHCARE LLC - EIR, 2006-07-19 |
January, 2011 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2011-01-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more